Companies in #Transcription Factor Modulation

Parabilis Medicines is a private clinical-stage biotechnology company developing precision oncology medicines for cancer targets historically considered undruggable. Its platform engineers stabilized peptide-based and small-molecule modulators against oncology targets including beta-catenin, ERG, and the Hedgehog pathway.